Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: Transient 'seronegative' antiphospholipid syndrome?

被引:0
|
作者
Miret, C
Cervera, R
Reverter, JC
GarciaCarrasco, M
Ramos, M
Molla, M
Font, J
Ingelmo, M
机构
[1] HOSP CLIN BARCELONA,SYSTEM AUTOIMMUNE DIS UNIT,BARCELONA 08036,SPAIN
[2] HOSP CLIN BARCELONA,DEPT HEMOTHERAPY & HEMOSTASIS,BARCELONA 08036,SPAIN
关键词
systemic lupus erythematosus; antiphospholipid syndrome; anticardiolipin antibody; lupus anticoagulant;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antiphospholipid syndrome (APS) is characterized by the presence of venous and arterial thrombosis, recurrent fetal losses and thrombocytopenia, associated with the presence of antiphospholipid antibodies (aPL). This syndrome may be ''primary'' or may be associated with other diseases, mainly systemic lupus erythematosus (SLE). However; some patients present the clinical picture of this syndrome but without evidence of aPL in their serum. The term ''seronegative'' APS has been proposed to categorize these patients. Herewith we present two patients with seronegativity for aPL at the time of a thrombotic event, but in whom these antibodies were detected 2 and 7 months later.
引用
收藏
页码:541 / 544
页数:4
相关论文
共 50 条
  • [41] Clinical Management of Thrombotic Antiphospholipid Syndrome
    Tumian, Nor Rafeah
    Hunt, Beverley J.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [42] Seronegative antiphospholipid syndrome: Myth or reality?
    Salle, V.
    REVUE DE MEDECINE INTERNE, 2020, 41 (04): : 265 - 274
  • [43] Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?
    Galli, M
    HAEMOSTASIS, 2000, 30 : 57 - 62
  • [44] A Diagnostic Dilemma: Catastrophic or Seronegative Antiphospholipid Syndrome
    Enescu, Christina D.
    Basida, Brinda
    Zalavadiya, Nirav
    Akram, Rayhaan
    Sarakbi, Housam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [45] The estimated prevalence of antiphospholipid antibodies and criteria-antiphospholipid syndrome in subjects with renal thrombotic microangiopathy
    Aluf, Ofir
    Parente, Silvia
    Radin, Massimo
    Campa, Loretta
    Gazzola, Valentina
    Olugbogi, Akindamola
    Tesio, Nicolo
    Ugo, Heinrich
    Zanetti, Edoardo
    Zevallos, Carla
    Versino, Elisabetta
    Lembo, David
    Roccatello, Dario
    Sciascia, Savino
    LUPUS, 2024, 33 (01) : 75 - 82
  • [46] A decrease in antiphospholipid antibodies before a thrombotic event
    Praprotnik, S
    Bozic, B
    CLINICAL RHEUMATOLOGY, 1996, 15 (03) : 298 - 300
  • [47] Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome
    Rodriguez-Sanz, Ana
    Martinez-Sanchez, Patricia
    Prefasi, Daniel
    Fuentes, Blanca
    Pascual-Salcedo, Dora
    Jesus Blanco-Banares, Maria
    Diez-Tejedor, Exuperio
    AUTOIMMUNITY, 2015, 48 (05) : 275 - 281
  • [48] The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome
    Del Ross, Teresa
    Ruffatti, Amelia
    Cuffaro, Serena
    Tonello, Marta
    Calligaro, Antonia
    Favaro, Maria
    Facchinetti, Myriam
    Hoxha, Ariela
    Punzi, Leonardo
    THROMBOSIS RESEARCH, 2015, 136 (05) : 883 - 886
  • [49] Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome
    Breen, Karen A.
    Seed, Paul
    Parmar, Kiran
    Moore, Gary W.
    Stuart-Smith, Sara E.
    Hunt, Beverley J.
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) : 423 - 429
  • [50] The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome
    Forastiero, Ricardo
    Martinuzzo, Marta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (11) : 1255 - 1263